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Abstract
Introduction: Dynamic changes in lactate concentrations in the critically ill may predict patient outcome more
accurately than static indices. We aimed to compare the predictive value of dynamic indices of lactatemia in the
first 24 hours of intensive care unit (ICU) admission with the value of more commonly used static indices.
Methods: This was a retrospective observational study of a prospectively obtained intensive care database of 5,041
consecutive critically ill patients from four Australian university hospitals. We assessed the relationship between
dynamic lactate values collected in the first 24 hours of ICU admission and both ICU and hospital mortality.
Results: We obtained 36,673 lactate measurements in 5,041 patients in the first 24 hours of ICU admission. Both
the time weighted average lactate (LACTW24) and the change in lactate (LACΔ24) over the first 24 hours were
independently predictive of hospital mortality with both relationships appearing to be linear in nature. For every
one unit increase in LACTW24 and LACΔ24 the risk of hospital death increased by 37% (OR 1.37, 1.29 to 1.45; P <
0.0001) and by 15% (OR 1.15, 1.10 to 1.20; P < 0.0001) respectively. Such dynamic indices, when combined with
Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, improved overall outcome prediction (P <
0.0001) achieving almost 90% accuracy. When all lactate measures in the first 24 hours were considered, the
combination of LACTW24 and LACΔ24 significantly outperformed (P < 0.0001) static indices of lactate concentration,
such as admission lactate, maximum lactate and minimum lactate.
Conclusions: In the first 24 hours following ICU admission, dynamic indices of hyperlactatemia have significant
independent predictive value, improve the performance of illness severity score-based outcome predictions and
are superior to simple static indices of lactate concentration.
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Introduction
In the critically ill, a higher admission blood lactate con-
centration is associated with a higher risk of death [1-8].
We recently reported that even within the current ‘nor-
mal range’ (< 2.00 mmol.L
-1) a higher admission blood
lactate concentration is associated with significantly
increased hospital mortality [4], a finding which suggests
that even the subtle perturbations of lactate homeostasis
may be important.
An elevated blood lactate concentration (a ‘static’
index) at any time point must be due to an increase in
its production, a decrease in its clearance, or both. Like-
wise, an increasing blood lactate concentration (a
‘dynamic’ index) must be due to increasing production,
decreasing clearance, or both simultaneously [9-11]. Sta-
tic derangements in lactate homeostasis during ICU stay
have become established as clinically useful markers of
increased risk of hospital and ICU mortality [1,3,4,12].
However, dynamic indices of lactate homeostasis, which
describe not only magnitude but also duration and
trend over time, may be even more useful in predicting
outcome. In support of this hypothesis, a number of
small single centre observational studies, principally in
patients with severe sepsis and septic shock, have
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any medium, provided the original work is properly cited.suggested that early changes in blood lactate concentra-
tion may be useful in identifying those at high risk of
death [5,6,13-16]. Furthermore, one interventional study
(n = 348) has suggested that interventions aimed at tar-
geting a dynamic reduction in lactate (20% per two
hours for the first eight hours) in the critically ill with
an abnormal admission lactate level may be associated
with reduced organ failure and increased survival [17].
However, the association between dynamic changes in
blood lactate concentration during the first 24 hours of
ICU admission and mortality has not yet been investi-
gated in a very large heterogeneous cohort of critically
ill patients. Furthermore, to our knowledge no study has
compared the ability of dynamic compared to static
indices of lactate homeostasis to predict mortality in the
critically ill.
To study this association, we examined the relation-
ship between six indices of lactate homeostasis in the
first 24 hours of ICU admission and both hospital and
ICU mortality. Three indices were static: i) admission
lactate (LACADM), ii) maximum lactate (LACMAX24), iii)
minimum lactate (LACMIN24), and three were dynamic:
iv) time weighted lactate (LACTW24), v) absolute change
in (delta) lactate (LACΔ24) and vi) percentage change in
lactate (LAC%Δ24).
Materials and methods
The data collection and data analysis for this study are
part of ongoing de-identified data auditing processes
across the participating hospitals, which have all waived
the need for informed consent. The Austin Hospital
Ethics Committee approved studies related to this
database.
Study population and data sources
The study population and data sources used in this
study are similar to those previously reported by us, in a
previous manuscript describing lactate homeostasis in
the critically ill [4]. In brief, this four-centre retrospec-
tive investigation of a prospectively gathered intensive
care database enrolled patients from January 2000 to
October 2004. However, in this study a minimum of
two lactate values collected over the first 24 hours were
necessary for inclusion into the study, with the latter
criteria needed to produce both a time weighted lactate
(LACTW24) and a change in lactate (LACΔ24)o v e rt h e
first 24 hours.
The blood lactate concentration data used for this
study were stored and retrieved electronically. We
obtained age, sex, use of mechanical ventilation, reason
for ICU admission (surgical and non-surgical, further
classified as trauma, cardiac/vascular, gastrointestinal
tract, neurological and thoracic/respiratory), and Acute
Physiology and Chronic Health Evaluation (APACHE) II
s c o r e[ 1 8 ]f r o mt h ee l e c t r o n ic data repositories of each
ICU, using data prospectively collected as part of the
Australian and New Zealand Intensive Care Society-
Centre for Outcome and Resources Evaluation
(ANZICS-CORE) quality assurance program [19].
The timing of lactate measurement (Rapilab, Bayer
Australia, Sydney, NSW, Australia) was at the discretion
of the managing critical care team. Laboratories in the
participating hospitals comply with standards of the
National Association of Testing Authorities [20] and the
Royal College of Pathologists of Australia [21].
Statistical analysis
To avoid the potential effect of surveillance bias due to
the increased blood lactate monitoring in more severely
ill patients, we calculated the time-weighted lactate con-
centration (LACTW24). In brief, time weighted average
lactate (LacTW) is an index of lactate homeostasis that is
proportional to the amount of time spent at each con-
centration in relation to the total period of time
observed. It is determined by summing the mean value
between consecutive time points multiplied by the per-
iod of time between consecutive time points and then
dividing by the total time (see Figure 1). This method
was modified from and used in accordance with an
approach previously used by Finney et al.t od e s c r i b e
hyperglycaemia [22].
The change in lactate over 24 hours (LACΔ24) was cal-
culated by regressing lactate against time for each indi-
vidual patient, with the regression slope representing the
projected change over a 24-hour period. To avoid undue
influence from extreme outliers, the maximal and mini-
mal slope values were capped in accordance with Tukey
[23]. Values that were found to be more than three
times the interquartile range to the left of the 25
th per-
centile or to the right of the 75
th percentile were consid-
ered to be extreme outliers. This resulted in a maximum
increase or decrease in slope over the first 24 hours of 5
mmol.L
-1.L A C %Δ24 describes the change in lactate over
a 24-hour period as the percentage change from the
admission blood lactate concentration.
The primary outcomes for analysis were hospital and
ICU mortality. We performed univariate analysis for
comparison between groups according to hospital mor-
tality status using chi-square test for proportions, Student
t-tests for normally distributed outcomes and, otherwise,
used Wilcoxon rank sum tests. We performed multivari-
ate analysis with all available predictors of hospital mor-
tality included in the models (gender, age, APACHE II,
mechanical ventilation, surgical admission and diagnosis
type). To account for changes in practice over the four-
year period of the study, the patient admission date was
included along with the specific hospital. To further
account for surveillance bias, the number of lactate
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included. After forcing all of the previous described vari-
ables into the multivariate model, both stepwise and
backwards elimination procedures were used to deter-
mine which lactate indices could independently aid in
the prediction of mortality. Six lactate indices specifically
relating to the first 24 hours of ICU admission were con-
sidered: Three indices were static: i) admission lactate
(LACADM), ii) maximum lactate (LACMAX24), iii) mini-
mum lactate (LACMIN24), and three were dynamic: iv)
time weighted lactate (LACTW24), v) absolute change in
(delta) lactate (LACΔ24) and vi) percentage change in lac-
tate (LAC%Δ24).
To determine if the relationship between lactate and
mortality was consistent acro s sp a t i e n ts u b g r o u p sa n d
study hospitals, we examined interactions between mea-
sures of lactate and other variables in the model. To
confirm that the potential relationships between lactate
and mortality were linear in nature, measures of lactate
w e r ed i v i d e di n t oq u i n t i l e sa n da n a l y s e da sc a t e g o r i c a l
variables, with quintiles chosen to provide a minimum
of 1,000 patients per category. Goodness of fit was
determined using the Hosmer and Lemeshow statistic.
All analyses were performed using SAS version 9.2 (SAS
Institute Inc., Cary, NC, USA). A two-sided P-value of
0.05 was considered to be statistically significant.
Having established which lactate variables had the
strongest relationships with mortality, to then determine
the true predictive capacity of these lactate variables, the
data were randomly divided into two groups, with 50%
of the data used as a derivation sample and the remain-
ing 50% of the data used as a validation sample. Univari-
ate models and multivariate models (with and without
the inclusion of lactate) were constructed from the deri-
vation sample for both hospital and ICU mortality. The
prediction equations were then applied to the holdout
sample and the improvement in the Area under the
Receiver Operating Characteristic Curve (AUC-ROC)
was recorded.
Results
We studied a heterogeneous cohort of 7,155 critically ill
patients of whom 5,041 had at least two measurements
over the first 24 hours (median 7; range 2 to 34) and
were included in the analysis. All indices of blood lac-
tate concentration over the first 24 hours (LACADM,
LACTW24,L A C MAX24,L A C MIN24), were significantly
higher in hospital non-survivors compared to survivors
(Table 1). The median decline in lactate over the first
24 hours (LACΔ24) and the median percentage decline
in lactate (LAC%Δ24) were significantly lower in non-sur-
vivors compared to survivors (Table 1).
Figure 1 Diagram describing the calculation of time weighted lactate (LacTW).
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We assessed the ability of both static (LACMAX24 and
LACMIN24)a n dd y n a m i c( L A C TW,L A C Δ24 and
LACΔ24%) indices of lactate homeostasis in the first 24
hours to predict hospital and ICU mortality bench-
marked against LACADM, the most commonly used sta-
tic measure (Table 2). The combination of LACTW and
LACΔ24, which assesses duration, magnitude and trend
of lactate derangement, resulted in the most significant
increase in ability to predict hospital death (Table 2).
Multivariate analysis
After adjusting for established predictors of mortality,
the lactate variables that were independently the most
predictive of hospital and ICU mortality were LACTW24
and LACΔ24 (Table 3). For every one unit increase in
LACΔ24 the risk of death increased by 15% (OR 1.15
(1.10 to 1.20) P < 0.0001) for hospital mortality and 18%
for ICU mortality (OR 1.18 (1.13 to 1.24) P < 0.0001).
When LACΔ24 was divided into quintiles the relation-
ship between LACΔ24 and mortality also appeared to be
well approximated by linearity (Figure 2). When the risk
of death was calculated based on the slope of the
LACΔ24, an increasing blood lactate concentration (slope
greater than 0 mmom.L
-1.24 hours
-1) was associated
with a greater increase in risk of hospital and ICU death
(OR 1.46 (1.23 to 1.74) P < 0.0001 and OR 1.71 (1.37 to
2.13) P < 0.0001, respectively). Furthermore, the risk of
Table 1 Comparison of hospital survivors vs.nonsurvivors
Variable Non survivors
(n = 974)
Survivors
(n = 4,067)
P-value
Male sex 59% (574) 62% (2,510) 0.11
APACHE II score 24.7 (8.0) 15.3 (6.7) < 0.0001
Age (yr) 65.7 (16.0) 59.7 (18.9) < 0.0001
Mechanical ventilation rate 84% (817) 60% (2443) < 0.0001
Surgical patients 32% (307) 51% (2087) < 0.0001
Diagnosis at admission
Cardiac and vascular 27% (265) 24% (979) 0.04
Thoracic and respiratory 20% (191) 18% (719) 0.16
Trauma 3% (27) 8% (343) < 0.0001
Neurological 18% (175) 12% (485) < 0.0001
Gastrointestinal tract diseases 13% (128) 21% (870) < 0.0001
Other 19% (188) 16% (671) 0.04
Hospital stay (days) 10 (4 to 25) 15 (8 to 30) < 0.0001
ICU stay (days) 3.0 (2.0 to 8.0) 3.0 (2.0 to 5.2) < 0.0001
Number of measurements 8 (6 to 10) 7 (5 to 9) < 0.0001
LACTW24 (mmom.L
-1) 2.20 (1.41 to 3.66) 1.41 (1.02 to 1.97) < 0.0001
LACΔ24 (mmom.L
-1) -0.21 (-1.66 to 0.73) -0.30 (-1.18 to 0.24) 0.009
LAC%Δ24 -13% (-49% to 42%) -22% (-55% to 21%) < 0.0001
LACADM (mmom.L
-1) 2.36 (1.45 to 4.29) 1.6 (1.08 to 2.49) < 0.0001
LACMIN24 (mmom.L
-1) 1.34 (0.92 to 2.16) 1.00 (0.74 to 1.31) < 0.0001
LACMAX24 (mmom.L
-1) 3.44 (1.99 to 6.20) 2.02 (1.37 to 3.20) < 0.0001
APACHE II, Acute Physiology and Chronic Health Evaluation II; LACADM, admission lactate; LACTW24, time weighted lactate; LACMAX24, maximum lactate; LACMIN24,
minimum lactate; LACΔ24, delta lactate; LAC%Δ24, percentage change in lactatein the first 24 hours
Table 2 Change in RAW (AUC-ROC) for indices of lactate homoeostasis in the first 24 hours and mortality
_NAME_ Hosp AUC-RAW P-value* ICU AUC-RAW P-value*
LACADM 0.648 ± 0.014 0.700 ± 0.017
LACΔ24% 0.558 ± 0.016 0.0002 0.572 ± 0.022 < 0.0001
LACΔ24 0.534 ± 0.016 < 0.0001 0.542 ± 0.022 < 0.0001
LACMAX24 0.694 ± 0.014 < 0.0001 0.769 ± 0.016 < 0.0001
LACTW24 0.705 ± 0.014 < 0.0001 0.769 ± 0.016 < 0.0001
LACMIN24 0.682 ± 0.014 0.002 0.723 ± 0.018 0.15
LACTW and LACΔ24 0.710 ± 0.01 < 0.0001 0.763 ± 0.01 < 0.0001
*compared to LACADM
AUC-RAW, Unadjusted Area Under Curve; LACADM, admission lactate; LACTW24, time weighted lactate; LACMAX24, maximum lactate; LACMIN24, minimum lactate;
LACΔ24, delta lactate-change in lactate in the first 24 hours; LAC%Δ24, percentage delta lactate-percentage change in lactate in the first 24 hours Hosp, hospital
mortality; ICU intensive care unit mortality
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greater in the increasing blood lactate concentration
group (n = 1,879) and the mildly decreasing blood lac-
tate concentration group (slope 0 to -1 mmom.L
-1.24
hours
-1, n = 1,680) when compared to a significantly
decreasing blood lactate concentration (less than -1
mmom.L
-1.24 hours
-1, n = 1,482) (OR 1.66 (1.35 to
2.04), OR 1.29 (1.02 to 1.62) respectively).
For every one unit increase in LACTW24 the risk of
hospital death increased by 37% (OR 1.37 (1.29 to 1.45)
P < 0.0001) and the risk of ICU mortality increased by
43% (OR 1.43 (1.35 to 1.52) P < 0.0001). When
LACTW24 was divided into quintiles and analysed as a
categorical variable, each quintile progressively showed
an increased risk in comparison to the lowest quintile
for both hospital and ICU mortality (Figure 3).
When prediction equations excluding measurements
of lactate were derived from 50% of the data and then
applied to the remaining holdout sample, the AUC for
hospital and ICU mortality was 0.820 ± 0.01 and 0.873
± 0.01 respectively. The inclusion of static and dynamic
measures of lactate homeostasis within the first 24
hours improved the prediction of hospital and ICU mor-
tality (Table 4). When LACTW24 and LACΔ24 were
added to the models of hospital mortality, the AUC-
ROC was found to increase to 0.831 ± 0.01 and 0.825 ±
0.009 respectively (Table 4). In both cases, this repre-
sented a statistical (P < 0.0001) improvement in the pre-
diction of mortality.
Interestingly, when LACMIN (a static measure) was
added to the models of hospital mortality, the AUC was
f o u n dt oi n c r e a s et o0 . 8 3 2±0 . 0 1( T a b l e4 ) .H o w e v e r ,
when we combined LACTW24 and LACΔ24 we found
that this resulted in the greatest improvement in the
prediction of both hospital and ICU mortality (Table 4),
compared to any other combination.
Discussion
Statement of key findings
In a large multi-centre, heterogeneous cohort of criti-
cally ill patients, we examined whether dynamic indices
of blood lactate concentration over the first 24 hours of
ICU admission were independently associated with
increased risk of hospital mortality. We found that
LACTW24 and the LACΔ24 were the indices of lactate
homeostasis within the first 24 hours that were indepen-
dently the most predictive of hospital mortality. A rising,
compared to a falling, blood lactate concentration over
the first 24 hours was associated with a significantly
increased risk of mortality. Furthermore, for every one
mmol L
-1 increase in LACTW24 and in LACΔ24 the risk
of hospital death increased by 37% and 15%, respec-
tively. When LACTW24 and LACΔ24 were separately
Table 3 Multivariate models for the prediction of hospital and ICU mortality
Effect Hospital mortality P-value ICU mortality p-value
Odds ratio (95% CI) Odds ratio (95% CI)
APACHE II score 1.13 (1.11 to 1.14) < 0.0001 1.13 (1.11 to 1.15) < 0.0001
Age (yr) 1.02 (1.02 to 1.03) < 0.0001 1.01 (1.00 to 1.02) 0.004
LACTW24 (mmom.L
-1) 1.37 (1.29 to 1.45) < 0.0001 1.43 (1.35 to 1.52) < 0.0001
LACΔ24 (mmom.L
-1) 1.15 (1.10 to 1.20) < 0.0001 1.18 (1.13 to 1.24) < 0.0001
Diagnosis* < 0.0001 < 0.0001
Mechanical ventilation 1.93 (1.52 to 2.45) < 0.0001 2.81 (1.95 to 4.05) < 0.0001
Hospital* 0.0001 0.006
Admission date (decreased risk per year) 0.91 (0.83 to 0.99) 0.04 0.88 (0.78 to 1.00) 0.05
Surgical patients 0.67 (0.53 to 0.84) 0.0007 0.80 (0.59 to 1.08) 0.15
Number of measurements 0.98 (0.95 to 1.01) 0.23 1.01 (0.97 to 1.04) 0.76
Female v male 0.96 (0.81 to 1.14) 0.66 0.99 (0.79 to 1.23) 0.90
*categorical variable, odds ratios excluded
APACHE II, Acute Physiology and Chronic Health Evaluation; LACTW24, time weighted lactate; LACΔ24, delta lactate-change in lactate in the first 24 hours
Figure 2 Adjusted* odds ratios for LacΔ24 referenced against
the lowest quintile. * adjusted for APACHE II, diagnosis, age,
gender, ventilation, surgery, admission date, hospital number of
measurements. 95% CI, 95% confidence interval; APACHE II, Acute
Physiology and Chronic Health Evaluation II; LACΔ24, delta lactate,
change in lactate in the first 24 hours; LacΔ24 change in lactate over
the first 24 hours.
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was found to increase significantly achieving close to
90% discrimination for ICU mortality. Furthermore, the
maximal increase in AUC-ROC was achieved by the
combination of both these dynamic indices (LACTW24
and LACΔ24) achieving close to 90% discrimination for
ICU mortality and close to 85% discrimination for hos-
pital mortality
Comparison with previous studies-static versus dynamic
While quite a number of studies, including our previous
study [4], have demonstrated that higher “static” indices
Figure 3 A d j u s t e d *o d d sr a t i o sf o rL a c TWreferenced against the lowest quintile. * adjusted for APACHE II, diagnosis, age, gender,
ventilation, surgery, admission date, hospital number of measurements. 95% CI, 95% confidence interval; APACHE II, Acute Physiology and
Chronic Health Evaluation II; LacTW, time weighted lactate over the first 24 hours.
Table 4 Change in adjusted Area under the Receiver Operating Characteristic Curve
NAME Hospital AUCADJ P-value* ICU AUCADJ P-value*
(1) Established risk factors 0.820 ± 0.01 0.873 ± 0.01
(1) + LACADM 0.822 ± 0.01 0.16 0.875 ± 0.01 0.24
(1) + LACΔ24% 0.824 ± 0.01 0.006 0.879 ± 0.01 0.009
(1) + LACΔ24 0.825 ± 0.01 0.005 0.879 ± 0.01 0.03
(1) + LACMAX24 0.827 ± 0.01 0.007 0.883 ± 0.01 0.015
(1) + LACTW24 0.831 ± 0.01 0.0001 0.887 ± 0.01 0.0005
(1) + LACMIN24 0.832 ± 0.01 < 0.0001 0.886 ± 0.01 < 0.0001
(1) + LACTW & LACΔ24 0.838 ± 0.01** < 0.0001 0.895 ± 0.01** < 0.0001
*compared to model (1) with established risk factors (APACHE II, diagnosis, age, gender, ventilation, surgery, date of admission and hospital)
**P < 0.01 compared to all individual measure of lactate
APACHE II, Acute Physiology and Chronic Health Evaluation II; Apache II, diagnosis, age, gender, ventilation, surgery, date of admission, mortality adjusting for
established predictors of mortality; AUCADJ, adjusted Area under the Receiver Operating Characteristic Curve; HVHF, high-volume hemofiltration; LACADM,
admission lactate; LACTW24, time weighted lactate; LACMAX24, maximum lactate; LACMIN24, minimum lactate; LACΔ24, delta lactate; LAC%Δ24, percentage change in
lactate in the first 24 hours
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LACMAX24 and LACMIN24) are associated with higher
ICU and hospital mortality [1,3,4,8,12] only a few stu-
dies have reported dynamic indices of lactate homeosta-
sis. In these studies, sustained hyperlactataemia
(generally regarded as more than six hours) was asso-
ciated with higher mortality and, as the duration of this
hyperlactaemia increased, the mortality rate also
increased [2,5,12,13,16,17]. However, it must be noted
that the majority of these studies were small, single cen-
tre, conducted in a single/specific diagnostic grouping
(that is, severe sepsis), commonly examined for only
short time periods after admission to ICU (under 24
hours) and were assessed in patients who had only a
small number of lactate samples taken in the first 24
hours. These methodological deficiencies have con-
founded previous attempts to investigate the indepen-
dent predictive value of dynamic indices of lactate in a
heterogeneous population of critically ill patients. Our
findings, however, for the first time demonstrate that
early dynamic indices of lactate hoemeostasis (LACTW24
and the LACΔ24) are independently associated with hos-
pital mortality in a large heterogeneous cohort of
patients. Our study expands this association between
decreasing blood lactate concentrations and mortality to
all patient groups and up to the first 24 hours in the cri-
tically ill. Thus, not only the magnitude and the dura-
tion of lactate derangement (LACTW24) but also the rate
of derangement in blood lactate concentration over the
first 24 hours (LACΔ24)h e l pi d e n t i f yp a t i e n t sa th i g h e r
risk of death. In this regard, our findings significantly
expand previous work which suggested that dynamic
changes in lactate concentration could be clinically use-
ful markers of patients at high risk of death [1,2,5,6,24].
However, to facilitate comparison with these previous
studies we conducted a separate analysis over the first
six hours after ICU admission and demonstrated that
lactate clearance was inversely associated with increased
risk of death at both univariate (P = 0.0001) and multi-
variate levels (P = 0.007) (Figure 4). These findings sug-
gest for the first time that LACΔ24 may be a clinically
useful index of lactate homeostasis in the critically ill.
While univariate results suggest a threshold value of 30
to 40% clearance over the first six hours, there is no
clear indication from the multivariate model as the risk
of death continues to decrease as the lactate clearance
increases. Furthermore, these findings are consistent
with previous studies suggesting that targeted reduction
of lactate may be a beneficial strategy in the critically ill
[14,17]. We also examined lactate clearance at 6 to 12
Figure 4 Raw and adjusted* odds ratios (95% CI) for death with LacΔ6 referenced against zero change. * adjusted for APACHE II,
diagnosis, age, gender, ventilation, surgery, admission date, hospital number of measurements. 95% CI, 95% confidence interval; APACHE II,
Acute Physiology and Chronic Health Evaluation II; LACΔ24, change in lactate in the first 24 hours; LacΔ6, lactate clearance at six hours.
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found to be statistically significant at either a univariate
or multivariate level (data not shown). In addition, while
the majority of the previous studies examined patients
with sepsis/septic shock, our cohort was heterogeneous.
While we determined those with sepsis had an increased
risk of mortality OR 1.60 (1.06 to 2.41) P =0 . 0 2 ,t h e r e
was no significant interaction between sepsis and
LACTW24 (P = 0.92) or sepsis and LACΔ24 (P = 0.10).
This indicates that there was no evidence in this cohort
to suggest that the relationship between lactate and
mortality differed significantly between those with and
without sepsis.
To our knowledge this is the first demonstration that
dynamic measures of lactate can be used to significantly
improve the prediction of mortality in a heterogeneous
cohort of critically ill patients. Moreover, both LACTW24
and LACΔ24 were positively associated with length of
stay in survivors suggesting that these indices are robust
and identify patients not only at high risk of mortality
but also those who are at high risk of significant mor-
bidity (data not shown). While individual dynamic mea-
sures do not outperform all the currently used static
measures, the combined measure of lactate dynamics
(LACTW24 and LACΔ24) could be the optimal early lac-
tate variable to predict mortality as it can out-perform
currently used static measures. This improved predictive
ability may rest in the ability of this dynamic composite
to assess the absolute magnitude, duration and rate of
reduction of lactate derangement. Further studies are
now required to confirm the clinical utility of this com-
posite dynamic measure.
Implications for clinicians
There is much interest in finding biomarkers that can
assist in the early identification of patients who are, or
continue to be, at high risk of death [25]. Our findings
suggest that dynamic changes in blood lactate concen-
tration over the first 24 hours may prove useful as a
widely available biomarker of increased risk of death.
Interestingly, in support of this hypothesis, goal directed
resuscitation in critically ill patients with septic shock
improves blood lactate concentrations over its six hours
of therapy [26]. Furthermore, a prospective study which
targeted reductions in blood lactate concentration goals
was equally effective as a strategy targeting central
venous oxygen saturation [25,27]. While our findings
are in broad agreement with this association between
‘physiological’ normalisation of lactate and improved
survival in the critically ill, further study is required
before our findings should be used as a therapeutic tar-
get in mixed cohorts of patients and over varying time
periods. However, clinicians confronted with a
persistently abnormal blood lactate should also be aware
of the fact that the absolute degree of derangement
(duration and magnitude) and the rate increase of this
derangement are associated with risk of death and
should continue to maintain a high index of suspicion
until these parameters have completely normalised.
Limitations of the study
Our study is retrospective in design and thus potentially
subject to systematic error and bias. However, all the
clinical and electronic data utilised were collected pro-
spectively in a large number of consecutive critically ill
patients in four ICUs, are numerical in nature and were
measured independently; thus, they were not amenable
to selection bias or unintended manipulation. Further-
more, 71% of all ICU patients admitted during the study
period (n = 7,155) had at least two blood lactate mea-
surements (n = 5,041) and were included in our analysis,
suggesting that our findings are generalisable and can be
applied to the majority of ICU patients. A number of
common therapeutic interventions, such as epinephrine
[28], metformin [29], nucleoside analogues in HIV [30],
high-volume hemofiltration (HVHF) with lactate-buf-
fered replacement fluids [31], can all affect lactate levels
and we did not have information on their use. However,
the influence of these potential confounding factors is
likely to be negligible given the small numbers of
patients in which these factors would have been present,
in relation to the size of the cohort; although presence
of these factors might alter the applicability of these
results to individual patients.
While our calculation of LACΔ24 assumes that the
kinetics of lactate is linear in nature, it is possible that it
may follow an alternative decay profile, that is, exponen-
tial. However, we feel this pragmatic assumption does
not positively bias the strength of the associations
demonstrated. Furthermore, we believe that more com-
plex modelling of lactate kinetics would obscure the
take-home message for clinicians at the bedside of the
association between rate of change of lactate concentra-
tion and mortality
The prognostic relevance of higher LACTW24 and
LACΔ24 derives from the statistical examination of a
large group of critically ill patients. Our results show
that the inclusion of these variables can significantly
improve the strength of predictive models of hospital
mortality. This suggests that future investigators devel-
oping early prognostic models in the critically ill should
consider the inclusion of these parameters (and the
composite measure of both together). However, it must
b en o t e dt h a tt h e ys h o u l dn o tb em i s u s e da sar e l i a b l e
prognostic sign in the individual patient, but in compar-
ing groups of patients. In individual patients, higher
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useful indicator pointing to the severity of illness and to
superimposed complications.
Future research
These dynamic lactate findings are novel and need to be
confirmed by similar studies in other countries and
large heterogeneous patient populations before they can
be considered to reflect a general biological principle.
Ideally, these studies should be conducted prospectively
with simultaneous collection of information on interven-
tions which may affect lactate. Furthermore, given the
lactate indices assessed in this study are not necessarily
the first in hospital lactate measurements and may not,
therefore, consider the effects of early resuscitative inter-
ventions, future prospective studies should collect all
lactate measurements (that is, including the emergency
department) to determine if the demonstrated relation-
ships are also observed during this earlier period.
In addition, if these studies confirm the value of
LACΔ24, then future studies could potentially focus on
this marker as a surrogate endpoint to assess the success
of early interventions in critically ill patients in the
resuscitative period.
Future studies developing new or refining current
severity of illness models in the critically ill should con-
sider the inclusion of measures of lactate homeostasis in
the first 24 hours. Our results suggest that the use of
dynamic measures may result in the greatest improve-
ment in predictive ability. In addition, it is worth noting
that our study was potentially limited by having to add
lactate measurements to the composite APACHE II
score, rather than its component parts, and that a com-
pletely re-derived risk prediction equation that includes
one or more index of lactate may further increase the
predictive ability over that shown in this study.
Conclusions
In conclusion, higher LACTW24 and LACΔ24 blood lac-
tate concentrations are associated with greater hospital
mortality. In the first 24 hours following ICU admission,
they have significant independent predictive value,
improve the performance of illness severity score-based
outcome predictions and are superior to simple static
measures of lactate concentration. Future studies should
be conducted to determine the clinical utility of the
composite measure of lactate derangement (magnitude,
duration and rate of correction) to predict mortality and
to determine potential the utility of LACΔ24 as a future
therapeutic target/trigger. While these dynamic mea-
sures do not have a routine role in daily clinical prac-
tice, clinicians should be especially alert to all patients
with a persistently deranged or rapidly rising blood lac-
tate concentration.
Key messages
￿ Static derangements in lactate homeostasis during
ICU stay have become established as clinically useful
markers of increased risk of mortality.
￿ Dynamic indices of lactate homeostasis, which
describe not only magnitude but also duration and
trend over time, may be even more useful in predict-
ing outcome.
￿ We demonstrated that higher lactate averaged over
24 hours (LACTW24) and an increasing trend in lac-
tate concentration over 24 hours (LACΔ24) is asso-
ciated with greater hospital mortality.
￿ Furthermore, the combination of these markers
out-performed all individual ‘static’ indices of lactate
homeostasis in predicting outcome in the critically ill.
￿ Clinicians should be especially alert in all patients
with a persistently deranged or rapidly rising blood
lactate concentration
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